company

Takeda

as of 2026-07-01
Monitor thisAsk about this
at a glance
13 trials sponsored · 21 assets in the graph
Synthesized from structured facts only — each point cited above.

Financials

SEC EDGAR XBRL · latest period per metric
No financials loaded for this company (may be non-US-listed — recorded as a gap, not faked).

Pipeline

21 assets
ITI-214 Dose AITI-214 Dose BITI-214 Dose CITI-214 Dose D (Elderly)ITI-214 Dose EITI-214 Dose FITI-214 Dose GITI-214 Dose HLuvadaxistatRamelteonRoflumilastSecond Generation Antipsychotics (SGA)Second generation antipsychoticTAK-041TAK-058TAK-063TAK-063 20 mgTAK-831 Oral SuspensionTAK-831 TabletVortioxetineondansetron

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
asset
ITI-214 Dose A
small molecule
drug
ITI-214 Dose B
small molecule
drug
ITI-214 Dose C
small molecule
drug
ITI-214 Dose D (Elderly)
small molecule
drug
ITI-214 Dose E
small molecule
drug
ITI-214 Dose F
small molecule
drug
ITI-214 Dose G
small molecule
drug
ITI-214 Dose H
small molecule
drug